Normal view MARC view ISBD view

Concurrent chemoradiotherapy with weekly versus three-weekly cisplatin in locally advanced head and neck squamous cell carcinoma

In Cochrane Database of Systematic Review
Contributor(s): Kannan S | Gupta T | Nair S | drshiva78in@gmail.com | Shivakumar T.
Material type: materialTypeLabelArticleSeries: Issues 1.Publisher: 2014Description: CD010906.Subject(s): Squamous cell carcinoma | Head and neck cancer | Cisplatin | Chemoradiotherapy | DDC classification: In: Cochrane Database of Systematic ReviewSummary: This is the protocol for a review and there is no abstract. The objectives are as follows: Primary objective To assess the efficacy of a weekly cisplatin regimen compared to a three-weekly regimen, given with curative intent to treat locally advanced HNSCC, in terms of overall survival (at five years). Secondary objective To assess the distant metastasis-free survival (at two years), disease-free survival (at two years) and the toxicity profile of the two regimens.
Tags from this library: No tags from this library for this title. Add tag(s)
Log in to add tags.
    average rating: 0.0 (0 votes)
Item type Current location Call number Status Date due Barcode
Articles Articles Tata Memorial Hospital
Available AR14562

This is the protocol for a review and there is no abstract. The objectives are as follows:

Primary objective
To assess the efficacy of a weekly cisplatin regimen compared to a three-weekly regimen, given with curative intent to treat locally advanced HNSCC, in terms of overall survival (at five years).

Secondary objective
To assess the distant metastasis-free survival (at two years), disease-free survival (at two years) and the toxicity profile of the two regimens.

There are no comments for this item.

Log in to your account to post a comment.

Powered by Koha